Retatrutide + Cagrilitide 5/5mg

Description

Retatrutide with Cagrilitide is an investigational combination of two injectable peptide agonists — retatrutide (a triple GIP/GLP-1/glucagon receptor agonist) and cagrilitide (an amylin analogue) — being explored together to produce synergistic, potentially superior weight loss and metabolic benefits compared to either agent alone.